• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

Comprehensive Overview of 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid (CAS No. 62614-48-6)

4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid (CAS No. 62614-48-6) is a chiral biphenyl derivative with significant applications in pharmaceutical and material science research. This compound, characterized by its 2-methylbutyl side chain and carboxylic acid functional group, has garnered attention for its potential in drug development and organic synthesis. Its unique stereochemistry and structural features make it a valuable intermediate for designing bioactive molecules.

The growing interest in chiral compounds like 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid aligns with the pharmaceutical industry's focus on enantioselective synthesis. Researchers are increasingly exploring such molecules for their ability to improve drug efficacy and reduce side effects. With the rise of personalized medicine and targeted therapies, this compound's role in developing small-molecule inhibitors and bioconjugates is being actively investigated.

From a synthetic chemistry perspective, CAS No. 62614-48-6 serves as a versatile building block. Its biphenyl core provides rigidity, while the carboxylic acid group allows for further functionalization through amidation, esterification, or other coupling reactions. Recent publications highlight its utility in creating liquid crystal materials and organic semiconductors, addressing the demand for advanced materials in display technologies and flexible electronics.

Analytical characterization of 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid typically involves techniques like HPLC, NMR, and mass spectrometry to confirm its purity and stereochemical integrity. The compound's logP and solubility profile make it particularly interesting for formulation scientists working on drug delivery systems. These properties are frequently searched by researchers optimizing bioavailability of lead compounds.

In the context of green chemistry trends, synthetic routes to 62614-48-6 are being reevaluated to minimize environmental impact. Recent advances in catalytic asymmetric synthesis and flow chemistry have shown promise for more sustainable production of this and related biphenyl derivatives. This aligns with the pharmaceutical industry's commitment to Process Intensification and waste reduction.

The compound's stability under various conditions is another area of active investigation. Thermal analysis studies (DSC and TGA) of 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid provide valuable data for process chemists developing scale-up protocols. Such information is crucial for technology transfer from laboratory to pilot plant scale, a common challenge in API manufacturing.

Patent literature reveals growing intellectual property activity surrounding biphenyl carboxylic acid derivatives, particularly in applications related to inflammatory diseases and metabolic disorders. The specific (2S)-2-methylbutyl configuration of CAS 62614-48-6 appears in several patent claims, highlighting its pharmacological relevance. This has led to increased searches for structure-activity relationships involving this scaffold.

From a regulatory standpoint, 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid requires proper handling as per standard laboratory safety protocols. While not classified as hazardous, appropriate PPE should be used when working with this compound, especially during weighing operations and solvent handling. These safety considerations are frequently queried by new researchers in online forums and databases.

The global market for fine chemicals like 62614-48-6 continues to expand, driven by demand from contract research organizations and academic laboratories. Suppliers are increasingly offering this compound with detailed certificates of analysis and stability data, responding to customer needs for reliable research materials. This trend reflects the broader movement toward reproducible science in chemical research.

Future research directions for 4'-(2S)-2-Methylbutyl-1,1'-biphenyl-4-carboxylic acid may explore its potential in proteolysis targeting chimeras (PROTACs) and other degrader technologies. The compound's structural features make it a candidate for linker design in these emerging therapeutic modalities. Such applications are generating significant interest in both medicinal chemistry circles and investment communities.

• 88038-94-2(4-(4-N-Propylphenyl)benzoic Acid)
• 59662-48-5(4-(4-Hexylphenyl)benzoic Acid)
• 59662-47-4(Np(4-N-pentylphenyl)benzoicacid)
• 59662-46-3(4'-Butylbiphenyl-4-carboxylic Acid)
• 58573-94-7(4-(4-Heptylphenyl)benzoic Acid)
• 59662-49-6(AC-55649)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)